Boston Scientific Corp
Close on Nov 20, 2026Market cap $60.84BP/E 17.0Yield –
Boston Scientific Adjusted Gross Profit (Non-GAAP, $M) by Quarter
Adjusted Gross Profit (Non-GAAP, $M) ($M)
Boston Scientific Adjusted Gross Profit (Non-GAAP, $M): $3,493M in Q3 2026, down 2.8% from a year earlier.
Where the Q3 2026 figure comes from
“|| Adjusted | $ | 3,493 | $ | 2,128 | $ | 1,364 | $ | (124) | $ | 1,240 | $ | 1,063 | $ | 0 | $ | 1,063 | $ | 0.73”
Source: Form 8-K_EARNINGS — FY2026Q3 (filed 2026-10-28) ↗
Reported in Form 8-K Item 2.02 Non-GAAP Reconciliations, Quarterly FOH Decks & Form 10-K/10-Q Footnotes.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up adjusted Gross Profit (Non-GAAP, $M)
- Adjusted Gross Margin (Non-GAAP, %)68.0% · Q3 2026
- GAAP Gross Margin, as Reported (%)66.7% · Q3 2026
- Gross Margin YoY Bridge — Pricing, Volume & Product Mix Impact (bps / %)-0.3% · Q3 2026
- Gross Margin YoY Bridge — Foreign Currency Fluctuations Impact (bps / %)-0.2% · Q3 2026
- Gross Margin YoY Bridge — Manufacturing & Other Period Expense Impact (bps / %)-1.1% · Q3 2026
Cite this data
StockData. (2026). Boston Scientific Adjusted Gross Profit (Non-GAAP, $M) ($M), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/ng-adj-gp
See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?